55. Macrophage Activation Syndrome
ACR on Air
00:00
The Future of Rheumatology
There are a lot more biomarkers being identified. I think over time, as we can get some of these lab tests that are clinically available and rapidly returned, it's really going to help us manage and identify patients. And then there are groups of patients that traditionally just have not done well with anything. That's particularly malignancy associated HLA, which is extremely difficult to manage.
Transcript
Play full episode
